Balance Labs Reports Director/Officer Changes & Comp.
Ticker: BLNC · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1632121
| Field | Detail |
|---|---|
| Company | Balance Labs, INC. (BLNC) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $350,000, $20,000,000, $1,000,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, officer-appointment, director-election
TL;DR
Balance Labs shuffled execs and board members, filed on 8/25.
AI Summary
Balance Labs, Inc. filed an 8-K on August 29, 2025, reporting events as of August 25, 2025. The filing indicates changes related to the departure or election of directors, appointment of officers, and compensatory arrangements for certain officers. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and executive compensation structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially if accompanied by compensatory arrangements, can indicate internal shifts that may affect company strategy and performance.
Key Players & Entities
- Balance Labs, Inc. (company) — Registrant
- August 25, 2025 (date) — Earliest event date
- August 29, 2025 (date) — Filing date
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of report, but the specific details of these changes are not provided in the excerpt.
Are there any new compensatory arrangements for officers mentioned?
Yes, "Compensatory Arrangements of Certain Officers" is listed as an item of report, suggesting that details regarding such arrangements are included in the filing.
What is the primary business of Balance Labs, Inc.?
Balance Labs, Inc. is classified under SERVICES-MANAGEMENT CONSULTING SERVICES [8742].
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing was on August 25, 2025.
What is the principal executive office address for Balance Labs, Inc.?
The principal executive offices are located at 407 Lincoln Road, Suite 701, Miami Beach, Florida 33139.
Filing Stats: 1,497 words · 6 min read · ~5 pages · Grade level 10.7 · Accepted 2025-08-29 08:45:35
Key Financial Figures
- $350,000 — ble to receive an annual base salary of $350,000, effective on the sooner of (i) 75 days
- $20,000,000 — y completes a capital raise of at least $20,000,000, and subject to annual review, the base
- $1,000,000,000 — any has raised a threshold aggregate of $1,000,000,000 in total capital, which shall be subjec
Filing Documents
- form8-k.htm (8-K) — 48KB
- ex10-1.htm (EX-10.1) — 72KB
- ex99-1.htm (EX-99.1) — 13KB
- ex99-1.jpg (GRAPHIC) — 5KB
- 0001641172-25-025898.txt ( ) — 320KB
- balancelabsco-20250825.xsd (EX-101.SCH) — 3KB
- balancelabsco-20250825_lab.xml (EX-101.LAB) — 33KB
- balancelabsco-20250825_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On August 29, 2025, the Company issued a press release announcing the appointment of Mr. Campbell as CEO and Mr. Farkas' leadership transition. A copy of the press release is being furnished as Exhibit 99.1 to this Form 8-K. The information furnished under this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 CEO Employment Agreement between Alan Campbell and Balance Labs, Inc. executed August 25, 2025 99.1 Press Release dated August 29, 2025 104 Cover Page Interactive Data File (embedded as Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BALANCE LABS, INC. Date: August 29, 2025 By: /s/ Michael D. Farkas Name: Michael D. Farkas Title: Chairman of the Board and President